uniQure Sets Sights on AMT-130 Marketing Authorization in UK After Positive MHRA Feedback
Market Chameleon (Thu, 30-Apr 7:36 AM)
Class Action Looms Over uniQure on Alleged Misstatements in Huntington’s Drug Trial—April 2026 Deadline for Investors
Market Chameleon (Mon, 9-Mar 10:34 AM)
